Overview

Single Dose Study of N1539 in the Treatment of Pain Secondary to Dental Impaction Surgery

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of single IV doses of N1539 after dental impaction surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Alkermes, Inc.
Treatments:
Ibuprofen
Meloxicam